Other Current Assets - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Theriva Biologics Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Theriva Biologics Inc
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Theriva Biologics Inc
F:SFY
Other Current Assets
$1.5m
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
1%
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.7B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
$2.9B
CAGR 3-Years
25%
CAGR 5-Years
5%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$3B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$575.4m
CAGR 3-Years
5%
CAGR 5-Years
31%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$681.9m
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
21%

See Also

What is Theriva Biologics Inc's Other Current Assets?
Other Current Assets
1.5m USD

Based on the financial report for Mar 31, 2024, Theriva Biologics Inc's Other Current Assets amounts to 1.5m USD.

What is Theriva Biologics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
1%

Over the last year, the Other Current Assets growth was -63%. The average annual Other Current Assets growth rates for Theriva Biologics Inc have been -5% over the past three years , 12% over the past five years , and 1% over the past ten years .

Back to Top